Another approach involved the adoptive transfer of FAP-targeted chimeric antigen receptor (CAR) T cells, which killed FAP+ CAFs and induced multiple beneficial stroma alterations, leading to delayed tumor growth and survival extension in mouse models of NSCLC and PDAC [125,126]. The gene discussed is FAP; the disease is non-small cell lung carcinoma.